ESR2 and ovarian cancer: A study done by De Stefano and colleagues to distinguish between normal and cancer ovarian cells found that; ERβ staining was more likely to be localized in the nucleus in normal ovarian tissue while it was more likely to be localized in the cytoplasm in ovarian cancer cells [66].